Vietnam Marks Medical Breakthrough With First Robotic Pediatric Brain Procedure
Europe and North America remain leaders in adoption. In 2023, Europe alone had over 3,500 surgical robotic systems and performed more than 280,000 robotic surgeries, according to MarketGrowthReports.
"Innovation like robot-assisted surgery isn't science fiction, it's the future of the health service," said UK Health Secretary Wes Streeting in The Scottish Sun.
That future is no longer limited to the West. It has arrived in Southeast Asia, specifically, Vietnam.
At Vinmec Central Park International Hospital (Ho Chi Minh City), surgeons performed the country's first pediatric stereo-electroencephalography (SEEG) using the AutoGuide™ robotic guidance system on a 9-year-old boy with drug-resistant epilepsy.
The patient, B.Q.K. from Hanoi, had suffered from epilepsy since 2021. Despite undergoing multiple treatments in Vietnam and abroad, his seizures persisted. For five years, his family sought a solution that could restore their son's quality of life and allow for seizure-free sleep.
That solution arrived in 2025.
On June 17, 2025, a surgical team led by Dr. Truong Van Tri, with support from Japanese epilepsy expert Assoc. Prof. Dr. Shunsuke Nakae, performed a high-precision resection.
The young patient after a life-changing breakthrough Handout
Using AutoGuide, Vinmec doctors successfully implanted electrodes deep into the orbitofrontal cortex and inferior frontal gyrus—regions densely packed with neural networks and blood vessels. The robot worked in tandem with advanced imaging tools, including a 3.0 Tesla MRI and multi-channel EEG systems, to visualize the brain and track seizure activity.
These technologies allowed the clinical team to identify the epileptogenic zone with high confidence, something that conventional surface EEG, PET, or MRI alone often fail to do in pediatric cases.
"For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri.
The patient experienced no postoperative neurological deficits. Within a month, he returned to regular play, and his seizure frequency decreased by more than 95%, a life-changing turnaround.
New Hope for Drug-Resistant Epilepsy Patients
According to the World Health Organization, approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. Surgery is often the most effective option for these patients, but it relies heavily on accurately localizing the epileptogenic zone.
This process becomes even more difficult in children, where traditional tools like scalp EEG, MRI, and PET often yield inconclusive results. Robotic SEEG offers a minimally invasive and highly accurate alternative.
Vinmec Central Park advances neurology through technology and international integration
By combining robotic precision with multidisciplinary expertise, Vinmec Central Park is now among the few hospitals in Asia capable of performing pediatric SEEG with robotic assistance.
Recognized as Vietnam's top private hospital system for expatriates and international patients (based on independent surveys), Vinmec is advancing the frontiers of neurology and precision medicine in Southeast Asia.
This achievement reflects Vinmec's long-term strategy to develop centers of excellence through cutting-edge technology, personalized treatment, and global collaboration.
As Vietnam continues to invest in AI, robotics, and precision healthcare, such milestones offer new possibilities for patients once deemed untreatable.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
2 hours ago
- Business Times
The AI race has big tech spending US$344 billion this year
[LONDON] If there's any lesson to take from the spending plans issued by the world's largest technology companies over the past two weeks, it's to never underestimate the fear of missing out. Microsoft, which set a US$24.2 billion capital spending record last quarter, plans to drop upwards of US$30 billion in the current period. similarly spent US$31.4 billion last quarter, almost double what it dropped a year ago, and is maintaining that level of investment. Google owner Alphabet raised its capital expenditures guidance this year to US$85 billion. Then there's Meta Platforms: The social networking giant lifted the low end of its forecast for 2025 capital expenditures and projected that costs will continue to grow at an even faster pace next year. Altogether, the four companies are expected to spend more than US$344 billion for the year, with much of it going to the data centres necessary to run artificial intelligence (AI) models. 'We have basically tripled capex investment in cloud due to AI,' Bloomberg Intelligence analyst Mandeep Singh said. The emphasis from virtually every company executive during this earnings season was on investing as quickly as possible to get ahead. 'We need the teams to execute at their very best to get the capacity in place as quickly and effectively as they can,' Microsoft chief financial officer Amy Hood told analysts in a call on Wednesday. Susan Li, Meta's CFO, said the goal of its own spend is to secure the advantage 'in developing the best AI models'. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Wall Street's response has been mixed. Meta was rewarded – in large part because the company posted a strong second-quarter sales beat and issued a rosy revenue forecast, signalling that the billions it's spending on AI are paying off. 'On advertising, the strong performance this quarter is largely thanks to AI unlocking greater efficiency and gains across our ad system,' chief executive officer Mark Zuckerberg said on an analyst call. Zuckerberg has plans to build several massive data centres and has been luring top AI researchers with compensation packages valued at hundreds of millions of US dollars. The company recently restructured its internal AI division, now referred to as Meta Superintelligence Labs, in an effort to build human-level AI capabilities and apply that technology across its products. Shares of the company have gained more than 8 per cent since it reported earnings on Wednesday. Amazon, on the other hand, failed to convince investors that its lavish spending has been worth it. The stock was down as much as 8.1 per cent on Friday after the company reported tepid sales from its cloud division. The results were 'especially disappointing' given the strong performance from Google's and Microsoft's own cloud services, according to Bloomberg Intelligence (BI). And the ongoing capital costs will not help. The operating margin for Amazon's cloud unit will continue to face pressure 'through 2026 as capital spending ramps up', BI analysts Poonam Goyal and Anurag Rana said. Alphabet's shares are essentially unchanged from last week when it reported earnings and issued guidance. The company raised its capital expenditures outlook by US$10 billion and expects to ramp up spending even more in 2026. chief executive officer Sundar Pichai explained that the investments are necessary to keep up with customer demand. 'Obviously, we are seeing strong momentum across our portfolio, and especially in cloud,' Pichai told analysts in a call on Jul 23. 'It's a tight supply environment, and we are investing more to expand.' Nikhil Lai, an analyst at Forrester, put it another way: If Google wants to keep up with rivals, he said, it has little choice but to follow suit: 'Google's hand is forced by OpenAI to spend tremendously on AI's infrastructure and applications.' Microsoft tied its AI investments directly to a 39 per cent jump in sales for its Azure cloud-computing division, which came in ahead of analysts' estimates. 'We continue to lead the AI infrastructure wave and took share every quarter this year,' chief executive officer Satya Nadella said in a call with analysts on Jul 30. 'In Microsoft's case, the returns are good,' Gil Luria, an analyst with DA Davidson, said. The only question now is whether Microsoft's customers are in turn seeing a decent return on investment, he said. 'That's where the test will be,' he said. 'If they don't, they are not going to increase that spend next year.' Apple's capital plans pale in comparison to its big tech peers. But the iPhone maker did raise its spending estimates, tying much of the increase to AI efforts. Apple's property, plant and equipment investments totalled US$9.47 billion in the nine months ended Jun 28, up nearly 45 per cent from a year ago. 'You are going to continue to see our capex grow,' chief financial officer Kevan Parekh told analysts on Thursday. 'It's not going to be exponential growth, but it is going to grow, substantially. And a lot of that's a function of the investments we are making in AI.' BLOOMBERG
Straits Times
13 hours ago
- Straits Times
Big Tech earnings strength is bright light in murky stock market
The Nasdaq 100 index remains up more than 30 per cent off its low from early April. NEW YORK – Wall Street had a lot riding on whether this week's big-tech earnings would meet increasingly high expectations. By and large, the companies delivered. The stock market finished the week on a down note with the selloff on Aug 1, which was in part sparked by mixed results from after the market closed on July 31, as well as a weak jobs report and fears about the economic impact of President Donald Trump's sweeping global tariffs. But for the most part, investors looking for strength from technology companies to justify their market leadership found plenty of it in their reports. 'The sector is proving itself to have something like Teflon status, as fundamentals look strong, revenue growth has come in quite significantly higher than expected, and margins remain relatively healthy,' said Kevin Gordon, senior investment strategist at Charles Schwab & Co. 'While things aren't perfect, and valuations are nearing a level that has acted as a ceiling in the past, we still have a high degree of optimism, especially as we go up the market-cap spectrum.' Alphabet started the season off by reporting strong sales, lifted by artificial intelligence. Last week, Apple posted its strongest revenue growth in more than three years, while Meta Platforms spiked to a record as it beat expectations and outlined aggressive spending on AI. Microsoft Corp. reported robust strength in its cloud business on the back of AI demand, enough to temporarily lift it to a US$4 trillion market capitalisation, only the second company ever to do so. The stock has risen for 10 straight weeks, its longest streak since 2023. Amazon was the exception, offering a tepid forecast due to relatively slow growth in its cloud-computing division and heavy investments into AI. From here, investors will turn to chip behemoth Nvidia, which reports at the end of the month. The Nasdaq 100 Index finished the week down 2.2 per cent, with much of the drop coming on Aug 1. However, the Nasdaq 100 remains up more than 30 per cent off its low from early April, while the Mag Seven Index is up more than 40 per cent. Those gains are raising questions among some Wall Street pros about whether the rally in tech has become overly stretched. The Nasdaq 100 is trading at nearly 27 times estimated earnings, well above its 10-year average of 22. Overall, however, none of the companies that have reported are showing dramatically weakening fundamentals, which is particularly important as uncertainty continues to swirl around the impact of trade policy and tariffs. More than 96 per cent of tech firms in the S&P 500 Index have topped expectations for profits, while roughly 93 per cent have for revenue, according to data compiled by Bloomberg. For the index overall, the beat rates stand at 82 per cent for earnings and 68 per cent for revenue. While Wall Street has long been broadly positive on big tech, last week's results reinforced it's continuing potential. The Magnificent Seven are expected to see earnings growth of 24.2 per cent this year, a dramatic increase from the 21.4 per cent pace that was predicted just a month ago, according to Bloomberg Intelligence data. Revenues are anticipated to rise 13.4 per cent, up from the 11.5 per cent pace seen in early July. Of course, that level of growth would represent a deceleration from last year, when the Mag Seven's net income rose 36 per cent and revenue gained 14 per cent. But the group continues to outgrow the broader market, which is expected to see earnings expand by 8.9 per cent in 2025 on revenue growth of 5.5 per cent. 'This slowing is understandable given how quickly these names were growing, and for how long,' said Mr Michael Nell, a senior investment analyst and portfolio manager at UBS Asset Management. 'We're not seeing the kind of dramatic deceleration that would be a cause for concern, just a reflection that these large companies can't grow to the sky forever.' Now investors are waiting on Nvidia, the chipmaker at the heart of the AI boom and the world's biggest company, which is scheduled to release its earnings on Aug 27. Advanced Micro Devices, its much-smaller rival in AI processors, reports on Aug 5. The bottom line for both is that big tech reaffirmed their intention to continue spending on AI, as Meta, Microsoft, Alphabet and Amazon all increased their plans for capital expenditures. That represents a cluster of encouraging data points for Nvidia, which derives more than 40 per cent of its revenue from those four companies, according to supply chain data compiled by Bloomberg. 'Use cases for AI are emerging and some companies are already seeing a payoff, meaning this isn't speculative anymore,' Mr Nell said. 'That doesn't mean big tech can't get ahead of themselves and pull back, but tech is on an inexorable march to be a larger and larger part of the market. That's been the trend my whole career, and I don't know why it would stop now.' BLOOMBERG
International Business Times
a day ago
- International Business Times
Vietnam Marks Medical Breakthrough With First Robotic Pediatric Brain Procedure
Robotic systems are fast becoming the new standard worldwide. According to Frontiers, the global medical robots market was valued at approximately US$27.7 billion in 2023, and is projected to hit US$127 billion by 2033, growing at a CAGR of 16.5%. Europe and North America remain leaders in adoption. In 2023, Europe alone had over 3,500 surgical robotic systems and performed more than 280,000 robotic surgeries, according to MarketGrowthReports. "Innovation like robot-assisted surgery isn't science fiction, it's the future of the health service," said UK Health Secretary Wes Streeting in The Scottish Sun. That future is no longer limited to the West. It has arrived in Southeast Asia, specifically, Vietnam. At Vinmec Central Park International Hospital (Ho Chi Minh City), surgeons performed the country's first pediatric stereo-electroencephalography (SEEG) using the AutoGuide™ robotic guidance system on a 9-year-old boy with drug-resistant epilepsy. The patient, B.Q.K. from Hanoi, had suffered from epilepsy since 2021. Despite undergoing multiple treatments in Vietnam and abroad, his seizures persisted. For five years, his family sought a solution that could restore their son's quality of life and allow for seizure-free sleep. That solution arrived in 2025. On June 17, 2025, a surgical team led by Dr. Truong Van Tri, with support from Japanese epilepsy expert Assoc. Prof. Dr. Shunsuke Nakae, performed a high-precision resection. The young patient after a life-changing breakthrough Handout Using AutoGuide, Vinmec doctors successfully implanted electrodes deep into the orbitofrontal cortex and inferior frontal gyrus—regions densely packed with neural networks and blood vessels. The robot worked in tandem with advanced imaging tools, including a 3.0 Tesla MRI and multi-channel EEG systems, to visualize the brain and track seizure activity. These technologies allowed the clinical team to identify the epileptogenic zone with high confidence, something that conventional surface EEG, PET, or MRI alone often fail to do in pediatric cases. "For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri. The patient experienced no postoperative neurological deficits. Within a month, he returned to regular play, and his seizure frequency decreased by more than 95%, a life-changing turnaround. New Hope for Drug-Resistant Epilepsy Patients According to the World Health Organization, approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. Surgery is often the most effective option for these patients, but it relies heavily on accurately localizing the epileptogenic zone. This process becomes even more difficult in children, where traditional tools like scalp EEG, MRI, and PET often yield inconclusive results. Robotic SEEG offers a minimally invasive and highly accurate alternative. Vinmec Central Park advances neurology through technology and international integration By combining robotic precision with multidisciplinary expertise, Vinmec Central Park is now among the few hospitals in Asia capable of performing pediatric SEEG with robotic assistance. Recognized as Vietnam's top private hospital system for expatriates and international patients (based on independent surveys), Vinmec is advancing the frontiers of neurology and precision medicine in Southeast Asia. This achievement reflects Vinmec's long-term strategy to develop centers of excellence through cutting-edge technology, personalized treatment, and global collaboration. As Vietnam continues to invest in AI, robotics, and precision healthcare, such milestones offer new possibilities for patients once deemed untreatable.
